SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000914121-20-001562
Filing Date
2020-04-22
Accepted
2020-04-22 17:17:48
Documents
1
Group Members
DR. JEFFREY R. JAY, M.D.MR. DAVID KROIN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D (AMENDMENT NO. 1) gr54950685-sc13da1.htm SC 13D/A 87105
  Complete submission text file 0000914121-20-001562.txt   88980
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Subject) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-33655 | Film No.: 20808578
SIC: 2834 Pharmaceutical Preparations

Mailing Address 165 MASON STREET, 3RD FLOOR GREENWICH CT 06830
Business Address 165 MASON STREET, 3RD FLOOR GREENWICH CT 06830 203 971-3300
GREAT POINT PARTNERS LLC (Filed by) CIK: 0001281446 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A